IRLAB Therapeutics

IRLAB A · Nasdaq Stockholm

Public Market Listing

IRLAB ANasdaq Stockholm

Nasdaq Stockholm primary exchange listing

Live quotes, historical charts, and market capitalization for IRLAB Therapeutics are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(3 total)
3Total Assets
0Approved
0Phase 3 / Filed
3Phase 1–2 / Early
1Diseases
Showing 3 of 3 assets
Target & Modality
Mesdopetam (IRL790)No recent activity
Phase 2
D3Small molecule
Parkinson's Disease
Phase 2
5-HT/norepinephrineSmall molecule
Parkinson's Disease
Phase 1/2
Undisclosed / early pipelineSmall molecule
Parkinson's Disease

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.